Marex Group (MRX) clearing head sells 14,427 shares, retains 242,658
Rhea-AI Filing Summary
Marex Group plc executive Thomas Texier, Group Head of Clearing, reported open-market sales of company ordinary shares. On April 1, 2026, he sold 9,589 shares at a weighted average price of $43.2754 and 4,838 shares at a weighted average price of $43.9743 under a pre-arranged Rule 10b5-1 plan entered into on September 10, 2025.
Following these transactions, Texier directly holds 242,658 ordinary shares of Marex Group plc. This figure includes 192,348 shares underlying deferred bonus plan awards, each representing a contingent right to receive one ordinary share upon vesting and settlement.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares | 9,589 | $43.2754 | $415K |
| Sale | Ordinary Shares | 4,838 | $43.9743 | $213K |
Footnotes (1)
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on September 10, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $42.77 to $43.7650 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $43.77 to $44.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The number of ordinary shares reported herein includes 192,348 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Key Figures
Key Terms
Rule 10b5-1 plan regulatory
weighted average price financial
deferred bonus plan awards financial
contingent right financial
FAQ
What insider transaction did Marex Group (MRX) report for Thomas Texier?
Was the Marex Group (MRX) insider sale by Thomas Texier under a Rule 10b5-1 plan?
What does the weighted average price mean in the Marex Group (MRX) Form 4 filing?